Monopar Therapeutics MNPR Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$3.89M+25.1% | -$5.2M-51.3% | -$3.44M-40.1% | -$2.45M+6.5% | -$2.62M+76.0% | ||
| $1.69M+53.3% | $1.1M+0.4% | $1.1M-14.1% | $1.28M-5.6% | $1.36M+386% | ||
| -$287.14K-139% | $738.68K— | —— | —— | -$770.97K-168% | ||
| $187.04K+126% | -$709.4K-761% | $107.24K+26.6% | $84.72K-83.1% | $502.03K+1,587% | ||
| -$3.47M-3.1% | -$3.37M-61.2% | -$2.09M-94.0% | -$1.08M+81.0% | -$5.66M-183% | ||
| $40.84M-47.8% | $78.29M+1,267% | $5.73M+372% | $1.21M-37.0% | $1.93M-86.6% | ||
| $35.25M+119% | $16.1M+347% | $3.6M+50.0% | $2.4M+50.0% | $1.6M— | ||
| -$5.58M+91.0% | -$62.19M-2,825% | -$2.13M-279% | $1.19M+464% | -$325.83K+97.7% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $200.2K-32.8% | $298.09K-21.9% | $381.56K+18.7% | $321.56K+145% | $131.13K+95.9% | ||
| -$200.2K— | $0-100% | $92.39M+29,260% | -$316.85K-174% | -$115.68K-100% | ||
| -$31.63K-132% | $99.5K+26,361% | $376+115% | -$2.55K-4,624% | -$54— | ||
| -$9.29M— | —— | $88.18M+42,194% | -$209.47K+96.6% | -$6.1M-115% | ||
| $799.63K— | —— | —— | —— | $119.51K+5,202% | ||
| $187.04K+126% | -$709.4K-761% | $107.24K+26.6% | $84.72K-83.1% | $502.03K+1,587% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $40.84M-47.8% | $78.29M+1,267% | $5.73M+372% | $1.21M-37.0% | $1.93M-86.6% | ||
| $35.25M+119% | $16.1M+347% | $3.6M+50.0% | $2.4M+50.0% | $1.6M— | ||
| -$31.63K-132% | $99.5K+26,361% | $376+115% | -$2.55K-4,624% | -$54— | ||
| -$0— | —— | —— | —— | $3M+200% | ||
| $25-99.5% | $5K— | $0-100% | $3.58K+321% | $850— | ||
| $291.73K+77.8% | $164.09K— | $0-100% | $117.44K+1,086% | $9.9K— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Monopar Therapeutics generate?
- Monopar Therapeutics (MNPR) generated -$10.0M in operating cash flow over the trailing twelve months.
- Where does Monopar Therapeutics's cash flow data come from?
- Every line is extracted from Monopar Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.